国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Advancing the Evaluation of Botanicals' Nephrotoxic Potential using Modern Toxicological Tools

Stefan Gafner

The evaluation of nephrotoxic potential in botanicals has been revolutionized by the application of modern toxicological tools. Traditional methods, such as animal models and histopathology, have limitations in predicting human toxicity accurately. This article highlights the advancements in toxicology that have enhanced the assessment of nephrotoxicity in botanicals. In vitro cellular models allow researchers to study the effects of botanical compounds on kidney cells, providing insights into cellular responses and mechanisms of toxicity. High-throughput screening enables rapid evaluation of multiple compounds, identifying those requiring further investigation. Omics technologies offer a comprehensive view of molecular changes induced by botanicals, aiding in identifying underlying mechanisms and potential biomarkers. The integration of these tools has important regulatory implications, aiding evidencebased decision-making and identifying safer botanical alternatives. Collaboration between disciplines is crucial for maximizing the benefits of these tools. Advancements in toxicological tools contribute to improved risk assessment, informed decision-making, and the development of safer botanical products, ensuring the well-being of consumers while harnessing the potential of botanical medicine.